Hims & Hers Health (HIMS) Stock
Direct to consumer telehealth and wellness subscription company. Here's the price, business snapshot, and what's worth knowing about Hims & Hers Health in July 2026.
Hims & Hers Health Inc (HIMS) is a direct‑to‑consumer telehealth and consumer health company offering prescription treatments, over‑the‑counter products and personalised care for sexual health, hair loss, skincare and mental wellbeing. The group combines online consultations, subscription services and product fulfilment to build recurring revenue and scale customer relationships. Investors should note the business is growth‑oriented: expansion of product categories and digital customer acquisition have driven top‑line growth, while profitability can fluctuate with marketing spend, retention rates and regulatory developments. Competition in telehealth and consumer health is strong, and outcomes depend on unit economics and customer lifetime value. Market capitalisation is around $11.16bn. This summary is general educational information, not personal financial advice; it is not a recommendation. Values can rise and fall and returns are not guaranteed — consider suitability, review company filings and consult a qualified financial adviser before investing.
Stock Performance Snapshot
Analyst Rating
Analysts suggest keeping HIMS & HERS stock as its value may not rise significantly soon.
Financial Health
HIMS & HERS is generating solid revenue and cash flow, with strong profit margins supporting growth.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
CHEMED CORP
Provides hospice and palliative care services to patients facing life-limiting illness
ALIGNMENT HEALTHCARE INC
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
Brookdale
A leading owner and operator of senior living communities in the United States.
Baskets Featuring HIMS
The GLP-1 Insurance Gap Reshaping Weight Care in 2026
Cigna's decision to drop coverage for popular GLP-1 weight-loss drugs like Wegovy and Zepbound for its employees signals a potential shift in employer-sponsored healthcare. This policy change could drive significant demand toward affordable direct-to-consumer telehealth platforms and alternative digital weight management programs.
Published: 3 June 2026
Explore BasketPharma Manufacturing | What's Next After TrumpRx
GlaxoSmithKline and Amgen are the latest pharmaceutical giants to join the TrumpRx platform, offering direct-to-consumer medications at reduced prices while committing to massive U.S. manufacturing investments. This evolving landscape creates compelling investment opportunities in domestic drug production facilities, supply chain logistics, and digital health aggregators that help patients navigate new pricing structures.
Published: 14 March 2026
Explore BasketOral Obesity Treatments: Investment Theme Explained
Novo Nordisk has launched the first oral GLP-1 weight loss medication, Wegovy, representing a major evolution in the obesity treatment landscape. This shift from injections to pills creates an investment opportunity in pharmaceutical innovators and the digital health companies enabling broad access.
Published: 6 January 2026
Explore BasketWalgreens Restructuring Explained: Investment Shifts
Following its acquisition by Sycamore Partners, Walgreens has gone private and split into five companies. This theme explores the investment opportunities created by the newly independent healthcare and retail entities.
Published: 2 September 2025
Explore BasketPharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Published: 19 August 2025
Explore BasketFollowing Buffett's Healthcare Bet
Warren Buffett's Berkshire Hathaway is making a major $2.1 billion bet on UnitedHealth, signaling a strategic shift toward the healthcare sector. This theme focuses on other health insurers and healthcare providers that could benefit from this renewed investor confidence.
Published: 15 August 2025
Explore BasketDigital Therapeutics & Prescription Apps
Software is becoming the new medicine. These carefully selected companies are developing FDA-cleared applications that treat everything from mental health to diabetes. With growing insurance reimbursement and massive scalability, these digital treatments represent healthcare's next frontier.
Published: 17 June 2025
Explore BasketEmployee Mental Health As A Benefit
Discover companies transforming workplace wellness through innovative mental health solutions. These carefully selected stocks represent businesses helping corporations attract and retain talent by offering digital therapy, virtual counseling, and wellness technologies as employee benefits.
Published: 17 June 2025
Explore BasketDigital Therapeutics
Software that works like medicine. These companies are creating clinically validated digital tools that treat and manage diseases just like traditional pharmaceuticals, but with the scalability of technology. Professional investors see enormous potential in this rapidly evolving healthcare frontier.
Published: 17 June 2025
Explore BasketMental Wellness Portfolio
Invest in the future of mental healthcare. These carefully selected companies are leveraging technology to make mental health treatment more accessible, personalized, and effective, creating significant growth opportunities in an expanding market.
Published: 17 June 2025
Explore BasketRest & Recovery
This carefully curated collection features companies at the forefront of sleep science and recovery technology. These stocks represent a growing market where innovation meets wellness, selected by professional analysts tracking the expanding health optimization trend.
Published: 17 June 2025
Explore BasketMind & Spirit
Invest in companies transforming mental healthcare through innovative treatments and technologies. These carefully selected stocks represent leaders in psychedelic therapeutics, telehealth platforms, and neurological treatments addressing the growing global demand for mental wellness solutions.
Published: 17 June 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring Revenue Focus
Subscriptions and repeat product sales can support predictable revenue, though retention and marketing costs have a strong influence on margins.
Digital‑first Healthcare
Online consultations and streamlined fulfilment enable scale, but regulatory shifts and competitive pressure can affect execution and growth.
Market & Competition
Rising telehealth adoption offers opportunity, while intense competition and pricing pressure mean outcomes can vary between companies.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
